Table 7.

Process and outcome indicators related with specific conditions, ACSH, 1 July 2018–30 June 2019.

Indicators	N	%
1. Prevention of PPH
Target population: women giving birth in health care facilities	575	85.2
Oxytocin use	490	85.2
Use of any uterotonic (including oxytocin)	528	91.8
2. Treatment of severe PPH
Target population: women with severe PPH	166	100
Oxytocin use	147	88.6
Ergometrine	8	4.8
Misoprostol	144	86.7
Any of the above uterotonics	166	100
Tranexamic acid	0	0
Removal of retained products	44	26.5
Hysterectomy	27	16.3
Proportion of cases with SMO	84	50.6
Mortality	3	1.8
3. Anticonvulsants for eclampsia
Target population: women with eclampsia	46	100
Magnesium sulfate	45	97.8
other anticonvulsant	2	4.3
Any anticonvulsant	46	100
Proportion of cases with SMO	33	71.3
Mortality	5	10.9
4. Prevention of cesarean section-related infection
Target population: women undergoing cesarean section	235	100
Prophylactic antibiotic during cesarean section	213	90.6
5. Treatment for sepsis
Target population: women with sepsis	130	100
Parenteral therapeutic antibiotics	120	92.3
Proportion of cases with SMO	29	22.3
Mortality	5	3.8
6. Ruptured uterus (n = 22)
Target population: women with ruptured uterus	22	100
Laparotomy	22	100
Laparotomy after 3 h of hospital stay	2	9.0
Proportion of cases with SMO	19	86.4
Mortality	1	4.5
7. Preterm birth (n = 119)
Target population: women having a preterm delivery after 3 h of hospital stay	106	89.1
Corticosteroids for fetal lung maturation	62	58.5
Early neonatal mortality	34	32.4

ACSH: Ayder Comprehensive Specialized Hospital; PPH: postpartum hemorrhage; SMO: severe maternal outcome.